Alessandro Moretta
Alessandro Moretta
School of Medicine, University of Genova, Italy
Verified email at unige.it
Title
Cited by
Cited by
Year
Innate or adaptive immunity? The example of natural killer cells
E Vivier, DH Raulet, A Moretta, MA Caligiuri, L Zitvogel, LL Lanier, ...
Science 331 (6013), 44-49, 2011
20852011
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
A Moretta, C Bottino, M Vitale, D Pende, C Cantoni, MC Mingari, ...
Annual review of immunology 19 (1), 197-223, 2001
18882001
Receptors for HLA class-I molecules in human natural killer cells
A Moretta, C Bottino, M Vitale, D Pende, R Biassoni, MC Mingari, ...
Annual review of immunology 14 (1), 619-648, 1996
9111996
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
D Pende, S Parolini, A Pessino, S Sivori, R Augugliaro, L Morelli, ...
The Journal of experimental medicine 190 (10), 1505-1516, 1999
8481999
Human bone marrow–derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms
ME Bernardo, N Zaffaroni, F Novara, AM Cometa, MA Avanzini, A Moretta, ...
Cancer research 67 (19), 9142-9149, 2007
8282007
NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non–major histocompatibility complex–restricted tumor cell lysis
M Vitale, C Bottino, S Sivori, L Sanseverino, R Castriconi, E Marcenaro, ...
The Journal of experimental medicine 187 (12), 2065-2072, 1998
8071998
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule
C Bottino, R Castriconi, D Pende, P Rivera, M Nanni, B Carnemolla, ...
The Journal of experimental medicine 198 (4), 557-567, 2003
7902003
Natural killer cells and dendritic cells: rendezvous in abused tissues
A Moretta
Nature Reviews Immunology 2 (12), 957-965, 2002
7612002
Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor
H Ikeda, B Lethé, F Lehmann, N Van Baren, JF Baurain, C De Smet, ...
Immunity 6 (2), 199-208, 1997
7231997
Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a …
R Maccario, M Podestà, A Moretta, A Cometa, P Comoli, D Montagna, ...
Haematologica 90 (4), 516-525, 2005
7182005
Unravelling natural killer cell function: triggering and inhibitory human NK receptors
L Moretta, A Moretta
The EMBO journal 23 (2), 255-259, 2004
6942004
Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra-and intracellular domains
N Wagtmann, R Biassoni, C Cantoni, S Verdiani, MS Malnati, M Vitale, ...
Immunity 2 (5), 439-449, 1995
6621995
Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity
A Pessino, S Sivori, C Bottino, A Malaspina, L Morelli, L Moretta, ...
The Journal of experimental medicine 188 (5), 953-960, 1998
6221998
Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to …
D Pende, P Rivera, S Marcenaro, CC Chang, R Biassoni, R Conte, ...
Cancer research 62 (21), 6178-6186, 2002
6112002
The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic
G Ferlazzo, D Thomas, SL Lin, K Goodman, B Morandi, WA Muller, ...
The Journal of Immunology 172 (3), 1455-1462, 2004
6062004
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
CS Brandt, M Baratin, EC Yi, J Kennedy, Z Gao, B Fox, B Haldeman, ...
Journal of Experimental Medicine 206 (7), 1495-1503, 2009
5882009
Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells
R Castriconi, C Cantoni, M Della Chiesa, M Vitale, E Marcenaro, R Conte, ...
Proceedings of the National Academy of Sciences 100 (7), 4120-4125, 2003
5742003
p46, a novel natural killer cell–specific surface molecule that mediates cell activation
S Sivori, M Vitale, L Morelli, L Sanseverino, R Augugliaro, C Bottino, ...
The Journal of experimental medicine 186 (7), 1129-1136, 1997
5671997
P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of …
A Moretta, M Vitale, C Bottino, AM Orengo, L Morelli, R Augugliaro, ...
The Journal of experimental medicine 178 (2), 597-604, 1993
5641993
Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation.
F De Benedetti, T Alonzi, A Moretta, D Lazzaro, P Costa, V Poli, A Martini, ...
The Journal of clinical investigation 99 (4), 643-650, 1997
5271997
The system can't perform the operation now. Try again later.
Articles 1–20